Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedAdded recruitment status indicating that the study is no longer recruiting participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were introduced, and the revision/versioning was updated to v3.6.0 while the older heading and revision note were removed.SummaryDifference0.3%

- Check11 days agoChange DetectedThe page shows an updated revision tag (v3.5.5) replacing the previous v3.5.4, indicating a new version of the page's metadata.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, representing a newer page version. This update pertains to metadata/formatting rather than substantive study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s footer has been updated to indicate the ClinicalTrials.gov site revision was bumped from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded the Bologna location entries 'Province Of Bologna' and 'Bologna, Province Of Bologna, Italy, 15-40138' and removed the lowercase versions. Updated the revision tag to v3.5.2, replacing v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedHepatocellular carcinoma tag added and a new resource entry for the Genetic and Rare Diseases Information Center. Page revision updated to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.